Just thinking out aloud here, the announcement states:
"may be an effective and safe treatment option for GI malignancies.
The most common types of GI cancers are:
Esophageal cancer Gastric (stomach) cancer Colorectal cancer Pancreatic cancer Liver cancer Gastrointestinal stromal tumors Anal cancer
Does our cohort have any additional ones of these along with those patients with bile duct cancer that would then increase confidence in the treatment if the latest data points to success?
IMU Price at posting:
10.8¢ Sentiment: Buy Disclosure: Held
